Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : Business SupportHouse : Sun Pharma

BSE146.155.75 (+4.1 %)

PREV CLOSE ( ) 140.40

OPEN PRICE ( ) 138.60

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 31946

TODAY'S LOW / HIGH ( )138.00 147.40

52 WK LOW / HIGH ( )109.2 240.95

NSE145.965.46 (+3.89 %)

PREV CLOSE( ) 140.50

OPEN PRICE ( ) 140.00

BID PRICE (QTY) 145.96 (5)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 370339

TODAY'S LOW / HIGH( ) 138.00 147.65

52 WK LOW / HIGH ( )109.3 241

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Audited

Net Sales

96.4

271.9

149.1

128.6

Total Expenditure

617.2

803.7

886

1157.7

PBIDT (Excl OI)

-520.8

-531.8

-736.9

-1029.1

Other Income

91.4

1.9

0.4

Operating Profit

-429.4

-531.8

-735

-1028.7

Interest

61.9

45.4

11.4

Exceptional Items

PBDT

-491.3

-577.2

-763

-1040.1

Depreciation

26.8

29.5

31.4

31.6

Profit Before Tax

-518.1

-606.7

-794.4

-1071.7

Tax

0.6

-9

0.7

1.6

Provisions and contingencies

Profit After Tax

-518.7

-597.7

-795.1

-1073.3

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

-518.7

-597.7

-795.1

-1073.3

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

-518.7

-597.7

-795.1

-1073.3

Equity Capital

324.5

Face Value (IN RS)

Reserves

Calculated EPS

-1.59

-1.84

-2.45

-3.30

Calculated EPS (Annualised)

-6.39

-7.36

-9.80

-13.23

No of Public Share Holdings

111406493

% of Public Share Holdings

34.33

PBIDTM% (Excl OI)

-540.24

-195.58

-494.23

-800.23

PBIDTM%

-445.43

-195.58

-492.95

-799.92

PBDTM%

-509.64

-212.28

-511.73

-808.78

PBTM%

-537.44

-223.13

-532.79

-833.35

PATM%

-538.07

-219.82

-533.26

-834.60

Notes

Risk Disclosures on Derivatives

Quarterly Results

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.